openPR Logo
Press release

Human Papillomavirus (HPV) Testing Market is expected to reach nearly US$ 1 Bn by the end of 2025 at a CAGR of 7.6%

12-29-2022 06:33 AM CET | Health & Medicine

Press release from: Persistence Market Research

Human Papillomavirus (HPV) Testing Market is expected to reach

The Human Papillomavirus (HPV) Testing Market is a sector of the healthcare industry that focuses on the diagnosis and management of HPV infections. HPV is a sexually transmitted virus that can cause genital warts and certain types of cancer, including cervical, anal, and oropharyngeal cancer.

There are several methods for detecting HPV infections, including DNA testing, Pap smears, and visual inspection with acetic acid (VIA). DNA testing is the most accurate method for detecting HPV, but it is also the most expensive. Pap smears, which involve collecting cells from the cervix and examining them under a microscope, are a less accurate but more affordable option. VIA involves applying a diluted vinegar solution to the cervix and looking for changes in the appearance of the tissue that may indicate the presence of HPV.

Request For Free Sample Report of "Human Papillomavirus (HPV) Testing Market"@ https://www.persistencemarketresearch.com/samples/11737

In addition to traditional laboratory-based testing, there are also several HPV tests that can be performed at the point of care (POC), such as self-sampling kits, which allow individuals to collect their own samples at home, and visual inspection with acetic acid (VIA), which is a low-cost method for identifying abnormal cervical cells.

Companies

Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene Co., Ltd. of Sun Yat-Sen University
Promega Corporation

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/11737

The HPV testing market is driven by factors such as increasing prevalence of HPV-related diseases, growing awareness about the importance of HPV vaccination and screening, and advances in HPV testing technology. However, the market is also faced with challenges such as low awareness and understanding of HPV among the general population, limited access to testing and vaccination services in certain regions, and high costs associated with some HPV tests.

Overall, the HPV testing market is expected to experience strong growth in the coming years, with increasing demand for HPV tests and advances in testing technology leading to the development of more accurate and convenient tests for the detection of HPV.

HPV screening tests are limited to women and this acts as a growth restraint

HPV infections can infect the genital areas of men including the skin on and around the. These infections can also be spread to the mouth and the throat. According to CDC, about 1% of sexually active men in the U.S. have genital warts at any given time.

Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men.

The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men. The selective product availability has restricted the growth of the market to a specific gender leading to slow growth over the forecast period.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/11737

Market Taxonomy

Product
DNA-based Test
RNA-based Test

End User
Hospitals
Clinics
Diagnostic Centers
Research Institutes

Applications
Molecular Diagnostics
Research Use

Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa

 
For More Premium Insights, Check out the Link:

Psoriasis Drugs Market -https://www.prnewswire.com/news-releases/psoriasis-drugs-market-is-predicted-to-progress-at-a-cagr-of-6-5-to-reach-a-valuation-of-us-21-48-bn-by-2031--301482350.html

Botulinum Toxin Market - https://www.prnewswire.com/news-releases/botulinum-toxin-market-is-set-to-expand-at-a-cagr-of-6-9-and-reach-a-valuation-of-us-10-7-bn-by-2031--301477267.html

Wearable Injectors Market - https://www.prnewswire.com/news-releases/wearable-injectors-market-expanding-at-a-cagr-of-around-11-8-over-the-forecast-period-2021-2031---persistence-market-research-301477856.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Papillomavirus (HPV) Testing Market is expected to reach nearly US$ 1 Bn by the end of 2025 at a CAGR of 7.6% here

News-ID: 2865917 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for HPV

Human Papillomavirus (HPV) Vaccine: Core Growth Enabler in the Rising Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Human Papillomavirus (HPV) Vaccine Industry Market Size Be by 2025? The market size for the Human Papillomavirus (HPV) vaccine has seen a swift expansion in the past few years. The market is projected to inflate from $5.8 billion in 2024 to $6.57 billion in 2025, marking
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033. The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period? The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026. Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962 Top Key Players: GSK, Merck. An Overview of the Impact of COVID-19 on HPV Vaccines Market: The emergence of COVID-19 has brought
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385 In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,